| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net cash provided by financing activities | 256,731 | 245,143 |
| Net decrease in cash, cash equivalents and restricted cash | -51,768 | -65,095 |
| Cash and cash equivalents at beginning of period | 192,672 | - |
| Cash and cash equivalents at end of period | 140,904 | - |
Disc Medicine, Inc. (IRON)
Disc Medicine, Inc. (IRON)